{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-24-017767","form_type":"8-K","ticker":"CRL","cik":"0001100682","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","filed_at":"2024-12-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.668197+00:00","generated_at":"2026-05-29T03:18:32.725769+00:00","sec_items":["2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Charles River amends credit agreement, cuts revolver to $2B, extends to 2029","bullets":["Revolving commitments reduced from $3B to $2B; maturity extended to December 13, 2029.","Subsidiary borrower Charles River Laboratories, Inc. added; obligations guaranteed by CRL and secured by assets.","Interest rates based on SOFR/EURIBOR/Base rate plus margin tied to leverage ratio (Level I-III).","Negative covenants limit additional indebtedness, liens, investments, mergers, and asset sales.","Covenants include interest coverage and leverage ratio tests; customary events of default."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-24-017767","json":"https://secwatch.observer/filing/0000950103-24-017767.json","markdown":"https://secwatch.observer/filing/0000950103-24-017767.md","text":"https://secwatch.observer/filing/0000950103-24-017767.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1100682/000095010324017767/0000950103-24-017767-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1100682/000095010324017767/dp222024_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T03:18:32.725769+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}